Home > Insider Trading > Filing (0001349929-15-000057)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1349929	Cancer Genetics Inc	CGIX	Services-Medical Laboratories (8071)	043462475

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1603489	J Edward Sitar	201 Route 17 North, 2Nd Floor C/O Cancer Genetics, Inc. Rutherford NJ 07070	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-11-12	5,000	$0.00	17,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.0001 Per Share	Warrant (right to buy)	Acquisiton	2015-11-12	5,000	$0.00	5,000	$5.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,000	2015-11-12	2020-11-12	No	4	P	Direct

Footnotes

The reported securities were purchased in an underwritten public offering which closed on November 12, 2015. The reported securities were issued pursuant to a prospectus supplement in connection with a takedown from the Company's shelf registration statement on Form S-3 (File No. 333-196374), filed with the SEC and effective on June 5, 2014.
The reported securities consist of one share of common stock, par value $0.0001 per share (the "Common Stock") and an accompanying warrant to purchase one share of Common Stock for $4.00 per share and warrant.